Table 1 Study population and characteristics
ADNI 1.5 T | ADNI 3 T | NACC | AIBL | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Diagnosis | NC | MCI | AD | NC | MCI | AD | NC | AD | NC | AD |
Number of cases | 229 | 69 | 188 | 47 | 69 | 35 | 356 | 209 | 93 | 14 |
Age (median + range) | 76 [60, 90] | 76 [55, 88] | 76 [55, 91] | 75 [70–86] | 76 [55, 88] | 72 [57, 89] | 74 [56, 94] | 77 [55, 95] | 71 [61, 86] | 73 [58, 82] |
Gender, male (percentage) | 119 (51.96%) | 39 (56.52%) | 101 (53.72%) | 18 (38.29%) | 39 (56.52%) | 12 (34.29%) | 126 (35.39%) | 95 (45.45%) | 48 (51.61%) | 6 (42.86%) |
Education (median + range) | 16 [6, 20] | 16 [6, 20] | 16 [4, 20] | 16 [7, 20] | 16 [6, 20] | 14 [7, 20] | 16 [0, 22] | 14.5 [2, 24] | N.A. | N.A. |
APOE+ (percentage) | 61 (26.64%) | 33 (47.83%) | 124 (65.96%) | 13 (27.66%) | 33 (47.83%) | 24 (68.75%) | 102 (28.65%) | 112 (53.59%) | 1 (1.01%) | 1 (7.17%) |
MMSE (median + range) | 29 [25, 30] | 26 [24, 30] | 23.5 [18, 28] | 30 [26, 30] | 26 [24, 30] | 23 [20, 27] | 29 [20, 30] | 22 [0, 30] | 29 [25, 30] | 18 [6, 22] |